CHDI is a private, not-for-profit research organization. We work with an international network of scientists to discover drugs that slow the progression or delay the onset of Huntington’s disease (HD).

We seek to accelerate scientific progress by serving as a collaborative enabler. We encourage and support cooperation and collaboration among HD researchers. Our strategy is to encourage researchers to develop practical ideas, useful research materials, and powerful technologies, often by providing financial support.

Our activities extend from exploratory biology to the identification and validation of therapeutic targets, and from drug discovery and development to clinical studies and trials.